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Abstract
Introduction: Implementation of the Surviving Sepsis Campaign (SSC) guidelines has been associated with
improved outcome in patients with severe sepsis. Resolution of lactate elevations or lactate clearance has also
been shown to be associated with outcome. The purpose of the present study was to examine the compliance
and effectiveness of the SSC resuscitation bundle with the addition of lactate clearance.
Methods: This was a prospective cohort study over 18 months in eight tertiary-care medical centers in Asia,
enrolling adult patients meeting criteria for the SSC resuscitation bundle in the emergency department.
Compliance and outcome results of a multi-disciplinary program to implement the Primary SSC Bundle with the
addition of lactate clearance (Modified SSC Bundle) were examined. The implementation period was divided into
quartiles, including baseline, education and four quality improvement phases.
Results: A total of 556 patients were enrolled, with median (25th to 75th percentile) age 63 (50 to 74) years,
lactate 4.1 (2.2 to 6.3) mmol/l, central venous pressure 10 (7 to 13) mmHg, mean arterial pressure (MAP) 70 (56 to
86) mmHg, and central venous oxygen saturation 77 (69 to 82)%. Completion of the Primary SSC Bundle over the
six quartiles was 13.3, 26.9, 37.5, 45.9, 48.8, and 54.5%, respectively (P <0.01). The Modified SSC Bundle was
completed in 10.2, 23.1, 31.7, 40.0, 42.5, and 43.6% patients, respectively (P <0.01). The ratio of the relative risk of
death reduction for the Modified SSC Bundle compared with the Primary SSC Bundle was 1.94 (95% confidence
interval = 1.45 to 39.1). Logistic regression modeling showed that the bundle items of fluid bolus given, achieve
MAP >65 mmHg by 6 hours, and lactate clearance were independently associated with decreased mortality -
having odds ratios (95% confidence intervals) 0.47 (0.23 to 0.96), 0.20 (0.07 to 0.55), and 0.32 (0.19 to 0.55),
respectively.
Conclusions: The addition of lactate clearance to the SSC resuscitation bundle is associated with improved
mortality. In our study patient population with optimized baseline central venous pressure and central venous
oxygen saturation, the bundle items of fluid bolus administration, achieving MAP >65 mmHg, and lactate clearance
were independent predictors of outcome.
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Despite many advances in our understanding and treat-
ments, epidemiologic studies across the globe have
shown an increasing incidence of severe sepsis with a
continued high mortality rate [1-3]. As a result, the
international Surviving Sepsis Campaign (SSC) devel-
oped guidelines to improve the standard of care for
severe sepsis. Such guidelines advocate early recognition,
broad-spectrum antibiotics, hemodynamic optimization
guided by invasive monitoring, corticosteroid, recombi-
nant human activated protein C, and lung protective
strategies in the form of the severe sepsis resuscitation
and management bundles [4]. While many studies have
examined the effectiveness of the bundles only in non-
randomized manners, their successful implementation in
America and Europe has been shown to be cost-effective
and associated with decreased mortality [5-7].
Crucial to implementing the guidelines and the severe
sepsis bundles is the utilization of lactate as an indicator
of global organ hypoperfusion and shock. While the
etiology of lactate elevations in severe sepsis is debata-
ble, it is well accepted as a resuscitation endpoint, an
indicator of severity, and a predictor of short-term and
long-term mortality [8-10]. Additionally, persistent ele-
vation of lactate has been shown to be associated with
poor outcome, such that a decrease in lactate (or lactate
clearance) during resuscitation is an independent predic-
tor for improved mortality [11-13].
Our study was a quality improvement effort in the
implementation of the SSC severe sepsis resuscitation
bundle in Asia, with the additional aim to examine the
effect of lactate clearance as a bundle item. Our hypoth-
esis was that completion of the bundle with addition of
lactate clearance will further decrease mortality com-
pared with completion of the bundle without lactate
clearance.
Materials and methods
Design and setting
This was a multi-national prospective quality improve-
ment cohort study performed in eight tertiary-care med-
ical centers in China, India, Korea, Singapore, and
Taiwan. The study was conducted at all participating
centers over an 18-month period starting on 1 July 2008
and ending on 31 December 2009. Participating hospi-
tals implemented the severe sepsis resuscitation bundle
as recommended by the SSC guidelines to improve the
standard of care, with the additional goal of lactate
clearance [4,14]. The implementation period was divided
into 3-month phases: baseline, education, and quality
improvement phases 1 to 4. The Institution Review
Board of the participating centers approved the study
and waived the need for patient’s written consent.
Patient data gathered during the course of the study
were entered into an Institution Review Board-approved
database at the study organization center, Loma Linda
University, CA, USA.
Bundle implementation and lactate clearance
Based on existing hospital staffing and resources, three
hospitals adopted a sepsis team model of implementa-
tion championed by intensivists. The severe sepsis resus-
citation bundle was initiated in the emergency
department (ED) and completed in the ICU. Patient
care was delivered by a focused multi-disciplinary team
led by the attending intensivist, similar to the well-
accepted trauma team model. The other five participat-
ing hospitals implemented the bundle via a nonteam
model, which was championed solely by the ED, with
initiation and completion of the bundle by ED physi-
cians and nurses as part of ED standard care.
Delivery of the bundle included lactate measurement,
blood cultures obtained prior to antibiotics, early antibiotic
administration, hemodynamic monitoring and support,
and mechanical ventilation per guidelines [4]. Hemody-
namic monitoring was achieved by central venous catheter
insertion for continuous monitoring of central venous
pressure (CVP) and central venous oxygen saturation
(ScvO2). Intra-arterial blood pressure monitoring with
insertion of a radial or femoral arterial catheter was pre-
ferred, especially if patients were on a vasoactive agent.
Hemodynamic support included the use of crystalloid
fluids, vasoactive and inotropic agents, and packed red
blood cell transfusion as appropriate to target optimal
CVP, mean arterial pressure (MAP), and ScvO2 as pre-
viously defined by the early goal-directed therapy (EGDT)
protocol [15]. Corticosteroid, glucose control, and lung-
protective strategies were provided at the discretion of the
treating physicians, and were not considered part of the
resuscitation bundle. Recombinant human activated pro-
tein C was not available at the participating hospitals.
During the study period, bundle completion was mon-
itored for compliance in each of the implementation
phases. A physician champion at each of the participat-
ing hospitals completed weekly audits of the bundle
implementation. A bundle compliance checklist was
completed for each consecutive patient meeting enroll-
ment criteria for the study (see below). Other informa-
tion recorded for each patient included demographics,
laboratories, Acute Physiology and Chronic Health Eva-
luation (APACHE) II score, vital signs, hemodynamic
measurements, source of infection, therapeutic interven-
tions up to 72 hours including ED and ICU lengths of
stay, and in-hospital mortality.
Completion of the Primary SSC Bundle included all of
the following items: lactate measured; blood cultures
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fluid bolus given; achieve CVP >8 mmHg by 6 hours;
achieve MAP >65 mmHg by 6 hours; and achieve ScvO2
>70% by 6 hours (Table 1). Completion of the Modified
SSC Bundle was defined as completion of the Primary
SSC Bundle and lactate clearance. Lactate clearance was
defined as any decrease in lactate within 12 hours from
baseline, or an initial lactate <2.0 mmol/l [12,16].
Patient selection
Adult patients over 18 years of age and meeting criteria
for initiating the severe sepsis resuscitation bundle in
the ED were considered for enrollment during the
weekly audit of bundle implementation. The inclusion
criteria were: two of four systemic inflammatory
response syndrome criteria; suspected or confirmed
infection; and systolic blood pressure <90 mmHg after a
1 liter crystalloid fluid bolus, lactate ≥4 mmol/l, or two
or more organ dysfunctions. The systemic inflammatory
response syndrome criteria included: temperature >38.3°
C or <36°C; heart rate >90 beats per minute; respiratory
rate >20 breaths per minute or arterial partial pressure
of carbon dioxide <32 mmHg; or a white blood cell
count >12, 000 per mm
3 or <4, 000 per mm
3,o rb a n d s
greater than 10%. Organ dysfunction was defined as:
creatinine >2.0 mg/dl or an increase >0.5 mg/dl; PaO2/
FiO2 <300; platelet count <100, 000/μl; International
Normalized Ratio >1.5; partial thromboplastin time >60
seconds; or total bilirubin >2.0 mg/dl.
Patients with trauma, active seizures, acute pulmonary
edema due to heart failure, a need for emergent surgery,
active bleeding, acute stroke, or a do-not-resuscitate
order were excluded from the study.
Outcome measures
The primary measures were compliance and in-hospital
mortality associated with completion of the Primary
SSC Bundle and the Modified SSC Bundle. Secondary
measures included bundle items independently asso-
ciated with in-hospital mortality.
Statistical analysis
Univariate analyses were conducted on patient demo-
graphics, laboratories, hemodynamics, and therapies
provided to the patient to assess normality and to test
the assumptions of the parametric and nonparametric
statistical tests conducted. Taken into consideration
were the following: age, gender, APACHE II score, care
team model, bundle completion, mechanical ventilation,
therapies in either the ED or ICU, length of stay in the
ED, ICU, and hospital, hemodynamic characteristics,
laboratory measurements, and infection source. The best
measure of central tendency and the corresponding
measure of variation for each of these factors stratified
by lactate clearance status were determined, reported,
and tested for differences using Pearson’sc h i - s q u a r e
test, Wilcoxon’s sum-rank test, or Student’s two-sample
t test as appropriate.
Trends in quarterly compliance to the bundle imple-
mentation for the Primary and Modified SSC Bundles
were assessed using analysis of variance for completion
of the individual bundle items over each of the six quar-
tiles. Comparisons of compliance to the Primary and
Modified SSC Bundles were made using Pearson’sc h i -
square test.
Multivariable logistic regression analysis was per-
formed for each of eight different models that sequen-
tially included another bundle item into a base model.
The base model included only the measurement of
serum lactate (lactate measured), adjusted for the effects
of age, gender, APACHE II score, and mechanical venti-
lation status. The -2 log-likelihood for the model includ-
ing all covariates was reported and used to compare
models with each sequentially included covariate. The
corresponding chi-square P value for the difference in
-2 log-likelihood identified models that significantly
improved with the inclusion of the new covariate. A
Bonferroni correction was performed to account for
multiple comparisons.
Statistical significance was defined at P <0.05. All ana-
lyses were performed using SAS version 9.2 (SAS Insti-
tute Inc., Cary, NC, USA).
Results
Five-hundred and fifty-six patients were enrolled in the
study, with median (25th to 75th percentile) age 63 (50
to 74) years, APACHE II score 22 (16 to 27), and lactate
4.1 (2.2 to 6.3) mmol/l (Table 2). Patients had a median
(25th to 75th percentile) length of stay of 5 (3 to 9)
hours in the ED and 4 (2 to 8) days in the ICU, and a
total hospital stay of 9 (4 to 16) days. A total of 67.1%
of patients were in septic shock on presentation, and
Table 1 Surviving Sepsis Campaign severe sepsis
resuscitation bundle
Primary SSC Bundle 1. Lactate measured
2. Blood cultures before antibiotics
3. Antibiotics administered by 3 hours
4. Fluid bolus given
5. Achieve CVP >8 mmHg by 6 hours
6. Achieve MAP >65 mmHg by 6 hours
7. Achieve ScvO2 >70% by 6 hours
Modified SSC Bundle Primary SSC Bundle + Lactate clearance
The Primary Surviving Sepsis Campaign (SSC) Bundle includes seven items.
The Modified SSC Bundle includes the Primary SSC Bundle and lactate
clearance. Lactate clearance is defined as any decrease in lactate within 12
hours from baseline, or an initial lactate <2.0 mmol/l. CVP, central venous
pressure; MAP, mean arterial pressure; ScvO2, central venous oxygen
saturation.
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All patients (n = 556) Lactate clearance (n = 331) No lactate clearance (n = 225) P value
Age (years) 63 (50 to 74) 61 (50 to 71) 65 (52 to 78) <0.01
Gender
Female 226 (40.6%) 133 (40.2%) 93 (41.3%) 0.79
Male 330 (59.4%) 198 (59.8%) 132 (58.7%)
Septic shock 373 (67.1%) 232 (70.1%) 141 (62.7%) 0.07
APACHE II score 22 (16 to 27) 19 (14 to 25) 25 (20 to 30) <0.01
APACHE II predicted mortality (%) 41.6 (20.4 to 59.7) 34.8 (20.4 to 56.1) 52.5 (31.5 to 72.6) <0.01
In-hospital mortality 166 (29.9%) 68 (20.5%) 98 (43.6%) <0.01
Primary SSC Bundle item completion 192 (34.5%) 174 (52.6%) 18 (8.0%) <0.01
Lactate measured 488 (87.8%) 331 (100.0%) 157 (70.4%) <0.01
Blood cultures before antibiotics 514 (92.4%) 313 (94.6%) 201 (89.3%) 0.02
Antibiotics administered by 3 hours 537 (96.6%) 324 (97.9%) 213 (94.7%) 0.04
Fluid bolus given 506 (91.0%) 310 (93.7%) 196 (87.1%) 0.01
Achieve CVP >8 mmHg by 6 hours 319 (57.4%) 232 (70.1%) 87 (38.7%) <0.01
Achieve MAP >65 mmHg by 6 hours 530 (95.3%) 326 (98.5%) 204 (91.5%) <0.01
Achieve ScvO2 >70% by 6 hours 250 (45.0%) 213 (64.4%) 37 (16.4%) <0.01
Care team model
Team 190 (34.2%) 164 (49.6%) 26 (11.6%) <0.01
Nonteam 366 (65.8%) 167 (50.5%) 199 (88.4%)
Mechanical ventilation 295 (53.1%) 143 (43.2%) 152 (67.6%) <0.01
Therapies in the ED
Amount of fluids (ml) 1, 500 (1, 000 to 2, 550) 1, 533 (1, 000 to 3, 000) 1, 350 (850 to 2, 300) <0.01
Vasopressor use
a 306 (55.0%) 188 (56.8%) 118 (52.4%) 0.31
Inotrope use
b 222 (39.9%) 134 (43.7%) 88 (40.6%) 0.48
Transfusion use 21 (3.8%) 12 (3.6%) 9 (4.0%) 0.82
Therapies in the ICU
Amount of fluids (ml) 6, 268 (3, 800 to 10, 200) 7, 943 (5, 200 to 11, 345) 4, 596 (3, 060 to 7, 100) <0.01
Vasopressor use
a 383 (68.9%) 223 (67.4%) 160 (71.1%) 0.35
Inotrope use
b 251 (45.1%) 141 (44.5%) 110 (49.8%) 0.23
Transfusion use 116 (20.9%) 65 (19.6%) 51 (22.7%) 0.39
Length of stay
ED (hours) 5 (3 to 9) 4 (3 to 6) 6 (4 to 15) <0.01
ICU (days) 4 (2 to 8) 4 (2 to 7) 4 (1 to 9) 0.53
Hospital (days) 9 (4 to 16) 9 (5 to 16) 9 (3 to 17) 0.07
Hemodynamics
Baseline CVP (mmHg) 10 (7 to 13) 9 (7 to 12) 11 (6 to 15) 0.04
Six-hour CVP (mmHg) 10 (8 to 14) 10 (8 to 13) 10 (7 to 15) 0.20
Baseline MAP (mmHg) 70 (56 to 86) 66 (56 to 83) 73 (57 to 90) 0.01
Six-hour MAP (mmHg) 78 (69 to 87) 80 (72 to 87) 73 (65 to 84) <0.01
Baseline ScvO2 (%) 77 (69 to 82) 78 (70 to 82) 73 (57 to 78) 0.01
Six-hour ScvO2 (%) 77 (71 to 82) 77 (72 to 82) 72 (60 to 79) 0.01
Laboratories
Lactate (mmol/l) 4.1 (2.2 to 6.3) 3.8 (1.9 to 5.8) 4.4 (3.0 to 6.9) <0.01
Blood culture positive 180 (32.4%) 99 (29.9%) 81 (36.0%) 0.25
Culture positive 191 (34.4%) 103 (31.1%) 88 (39.1%) 0.05
White blood count (10
3/mm
3) 13.4 (6.9 to 20.4) 13.4 (7.2 to 20.2) 13.3 (6.7 to 22.0) 0.92
Hemoglobin (g/dl) 11.6 (9.7 to 13.2) 11.5 (9.6 to 13.2) 11.6 (9.8 to 13.4) 0.80
Platelet count (x10
9/l) 150.0 (68.0 to 246.0) 162.0 (70.0 to 254.0) 136.0 (67.0 to 219.0) 0.07
International Normalized Ratio 1.4 (1.2 to 1.7) 1.3 (1.1 to 1.5) 1.5 (1.2 to 1.8) <0.01
Creatinine (mg/dl) 2.0 (1.3 to 3.1) 2.0 (1.2 to 2.9) 2.0 (1.4 to 3.1) 0.24
Total bilirubin (mg/dl) 1.1 (0.7 to 2.4) 1.0 (0.6 to 2.2) 1.4 (0.7 to 3.4) <0.01
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Baseline (25th to 75th percentile) CVP, MAP, and
ScvO2 values were 10 (7 to 13) mmHg, 70 (56 to 86)
mmHg, and 77 (69 to 82)%, respectively. Pneumonia
(41.9%) was the most common source of infection. In-
hospital mortality was 29.9%.
Patients having lactate clearance had all Primary SSC
Bundle items completed signi f i c a n t l ym o r et h a nt h o s e
patients without lactate clearance (Table 2). Patients
with lactate clearance had lower APACHE II score (P
<0.01) and baseline lactate (P <0.01). The lactate clear-
ance group had lower CVP and MAP but higher ScvO2
at baseline compared with the patients without lactate
clearance (P <0.05). Patients with lactate clearance were
more in the team care model than the nonteam model
(P < 0.01) and received more fluid resuscitation both in
t h eE Da n dI C U( P < 0 . 0 1 ) ,w i t has h o r t e rl e n g t ho fs t a y
in the ED (P <0.01). Patients with lactate clearance had
mortality of 20.5% compared with 43.6% in those
patients with no lactate clearance (P <0.01).
Completion of the Primary SSC Bundle over the six
quartiles of implementation was 13.3, 26.9, 37.5, 45.9,
48.8, and 54.5%, respectively (P <0.01). The Modified
SSC Bundle (including lactate clearance) was completed
in 10.2, 23.1, 31.7, 40.0, 42.5, and 43.6% patients, respec-
tively (P <0.01) (Table 3 and Figure 1). Patients with the
Primary SSC Bundle completed compared with not
completed had mortality of 24.5% (95% confidence
interval = 18.6 to 31.2) versus 32.7% (95% confidence
interval = 27.9 to 37.8) (P = 0.04). Patients with the
Modified SSC Bundle completed compared with not
completed had mortality of 17.9% (95% confidence
interval = 12.3 to 24.7) versus 34.8% (95% confidence
interval = 30.1 to 39.7) (P <0.01) (Figure 2). Completion
of the Primary SSC Bundle resulted in a relative risk of
death reduction (RRR) of 0.251 (95% confidence interval
= 0.007 to 0.442), and completion of the Modified SSC
Bundle had a relative risk of death reduction of 0.486
(95% confidence interval = 0.274 to 0.642). The ratio of
the relative risk of death reduction for the Modified SSC
Bundle compared with the Primary SSC Bundle was
1.94 (95% confidence interval = 1.45 to 39.1).
Logistic regression models with sequential inclusion of
each bundle item as the independent variable showed
that the bundle items of fluid bolus given, achieve MAP
>65 mmHg by 6 hours, and lactate clearance were
Table 3 Bundle compliance by implementation phases: baseline, education, and quality improvement phases 1 to 4
All patients
(n = 556)
Baseline
(n = 128)
Education
(n = 104)
QI1
(n = 104)
QI2
(n = 85)
QI3
(n = 80)
QI4
(n = 55)
P value
Lactate measured 488 (87.8) 99 (77.3) 78 (76.5) 100 (96.2) 84 (98.8) 77 (96.3) 50 (90.9) <0.01
Blood cultures before antibiotics 514 (92.4) 101 (78.9) 97 (93.3) 99 (95.2) 82 (96.5) 80 (100.0) 55 (100.0) <0.01
Antibiotics administered by 3 hours 555 (99.8) 128 (100.0) 103 (99.0) 104 (100.0) 85 (100.0) 80 (100.0) 55 (100.0) 0.50
Fluid bolus given 506 (91.0) 98 (76.6) 102 (98.1) 100 (96.2) 75 (88.2) 78 (97.5) 53 (96.4) <0.01
Achieve CVP >8 mmHg by 6 hours 319 (57.4) 55 (43.0) 58 (55.8) 59 (56.7) 57 (67.1) 52 (65.0) 38 (69.1) <0.01
Achieve MAP >65 mmHg by 6 hours 530 (95.3) 117 (92.1) 103 (100.0) 100 (96.2) 80 (94.1) 78 (97.5) 52 (94.5) 0.08
Achieve ScvO2 >70% by 6 hours 250 (45.0) 23 (18.0) 33 (31.7) 58 (55.8) 51 (60.0) 50 (62.5) 35 (63.6) <0.01
Lactate clearance 331 (59.5) 68 (53.1) 43 (41.3) 63 (60.6) 60 (70.6) 61 (76.3) 36 (65.5) <0.01
Primary SSC Bundle completion 192 (34.5) 17 (13.3) 28 (26.9) 39 (37.5) 39 (45.9) 39 (48.8) 30 (54.5) <0.01
Modified SSC Bundle completion 162 (29.1) 13 (10.2) 24 (23.1) 33 (31.7) 34 (40.0) 34 (42.5) 24 (43.6) <0.01
Results reported as count (column %). CVP, central venous pressure; MAP, mean arterial pressure; QI, quality improvement; ScvO2, central venous oxygen
saturation; SSC, Surviving Sepsis Campaign.
Table 2 Patient characteristics during the entire study period, comparing lactate clearance with no lactate clearance
(Continued)
Albumin (g/dl) 3.0 (2.5 to 3.6) 3.1 (2.6 to 3.7) 2.8 (2.3 to 3.5) 0.01
PaO2/FiO2 ratio 163.0 (86.0 to 320.7) 251.1 (95.0 to 391.0) 125.5 (77.0 to 217.0) <0.01
Source of infection 0.13
Pneumonia 233 (41.9%) 136 (41.1%) 97 (43.1%)
Urinary tract infection 93 (16.7%) 64 (19.3%) 29 (12.9%)
Intra-abdominal 108 (19.4%) 68 (20.5%) 40 (17.8%)
Skin/cellulitis 33 (5.9%) 17 (5.1%) 16 (7.1%)
Other/unknown 89 (16.0%) 46 (13.9%) 43 (19.1%)
Patient characteristics during the entire study period in the lactate clearance group compared with no lactate clearance. Results reported as either the count
(column %) or as the median (25th to 75th percentile). APACHE, Acute Physiology and Chronic Health Evaluation; CVP, central venous pressure; ED, emergency
department; MAP, mean arterial pressure; SSC, Surviving Sepsis Campaign; ScvO2, central venous oxygen saturation.
aNorepinephrine, dopamine, phenylephrine,
or vasopressin.
bDopamine or dobutamine.
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ing odds ratios (95% confidence interval) of 0.47 (0.23
to 0.96), 0.20 (0.07 to 0.55), and 0.32 (0.19 to 0.55),
respectively, in the final model (Table 4).
Discussion
The rationale for implementing the severe sepsis care
bundles has been that the compliance to the bundle
would translate into better patient outcomes. Several
studies showed that improvements in survival were
related to the number of bundle interventions com-
pleted [16-18]. Recently, another study showed that
mortality was significantly lower even if completion of
the 6-hour resuscitation bundle was achieved later at 18
hours compared with not completing the bundle at all
[19]. Despite a number of observational studies indicat-
ing protocol-driven EGDT and the severe sepsis bundle
to be associated with reduced mortality, EGDT is under-
used even with formal bundle implementation in place
[20]. Many potential barriers ranging from patient to
clinician to organizational factors have been identified as
stifling the more widespread compliance to the bundle.
In the present study, we showed that implementation of
the SSC resuscitation bundle in Asia was achievable
with a compliance >50% after 1 year of quality improve-
ment. Overall compliance was expectedly less through-
out the study period with the addition of lactate
clearance as a bundle item.
Our patients with optimal baseline CVP and ScvO2
contrast those of the original study examining EGDT.
Optimizing preload remains a cornerstone for resuscita-
tion of patients in shock; however, the use of CVP as a
measure of fluid responsiveness has been challenged
[21]. Evidence demonstrated a poor relationship
between CVP and blood volume as well as its ability to
predict a hemodynamic response to a fluid bolus. Irre-
spective of the debate and contrast to the low initial
CVP observed in the original EGDT study, our patients
did not require much fluid administration according to
the target CVP recommended during the 6 hours of the
resuscitation bundle. With respect to targeting ScvO2,
the original EGDT study examined a patient population
with initial ScvO2 <50% [15]. This finding has not been
consistently observed in other studies, including ours.
Another study showed that the number of severe sepsis
patients with ScvO2 <50% was only 1%, with the rest of
the patients having normal mean mixed venous oxygen
saturation (SvO2)o rS c v O 2 values [22]. In fact, some
studies have shown supranormal levels of ScvO2,w h i c h
is probably due to the lack of effective tissue oxygen
extraction that is seen in patients with sepsis [23].
Given the barriers and controversies in implementing
EGDT, an approach utilizing noninvasive hemodynamic
monitoring technology has been suggested [24,25].
Figure 1 Surviving Sepsis Campaign bundle completion.
Primary Surviving Sepsis Campaign (SSC) Bundle completion versus
Modified SSC Bundle completion (includes lactate clearance) from
baseline to the end of the study period. QI, quality improvement.
Figure 2 Mortality differences for the Surviving Sepsis
Campaign bundles. Mortality differences for the Primary Surviving
Sepsis Campaign (SSC) Bundle and the Modified SSC Bundle
(includes lactate clearance). Patients with the Primary SSC Bundle
completed compared with not completed had mortality of 24.5%
(95% confidence interval = 18.6 to 31.2) versus 32.7% (95%
confidence interval = 27.9 to 37.8). Patients with the Modified SSC
Bundle completed compared with not completed had mortality of
17.9% (95% confidence interval = 12.3 to 24.7) versus 34.8% (95%
confidence interval = 30.1 to 39.7). The ratio of the relative risk of
death reduction for the Modified SSC Bundle compared with the
Primary SSC Bundle was 1.94 (95% confidence interval = 1.45 to
39.1).
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Model I Model II Model III Model IV Model V Model VI Model VII Model VIII
Bundle item OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI
1. Lactate measured 1.96 (0.99 to
3.90)
2.03 (1.02 to
4.05)
2.03 (1.02 to
4.05)
2.27 (1.12 to
4.62)
2.38 (1.15 to
4.96)
2.67 (1.24 to
5.75)
2.63 (1.22 to
5.70)
4.06 (1.84 to
8.97)
2. Blood cultures before
antibiotics
0.67 (0.29 to
1.54)
0.67 (0.29 to
1.54)
0.68 (0.29 to
1.59)
0.68 (0.29 to
1.59)
0.79 (0.33 to
1.90)
0.78 (0.33 to
1.89)
0.80 (0.33 to
1.94)
3. Antibiotics administered by 3
hours
1.14 (0.30 to
4.38)
1.06 (0.27 to
4.11)
1.09 (0.28 to
4.28)
1.18 (0.26 to
5.28)
1.20 (0.27 to
5.36)
1.35 (0.28 to
6.55)
4. Fluid bolus given 0.50 (0.25 to
0.99)
0.50 (0.25 to
0.99)
0.46 (0.23 to
0.93)
0.45 (0.22 to
0.92)
0.47 (0.23 to
0.96)
5. Achieve CVP >8 mmHg by 6
hours
0.89 (0.57 to
1.37)
1.05 (0.67 to
1.66)
1.01 (0.60 to
1.69)
1.21 (0.71 to
2.06)
6. Achieve MAP >65 mmHg by
6 hours
0.16 (0.06 to
0.44)
0.16 (0.06 to
0.43)
0.20 (0.07 to
0.55)
7. Achieve ScvO2 >70% by 6
hours
1.10 (0.65 to
1.87)
1.43 (0.82 to
2.51)
8. Lactate clearance 0.32 (0.19 to
0.55)
-2 log-likelihood 531.04 530.18 530.14 526.28 525.98 508.84 508.72 490.73
Change in -2 log-likelihood (c
2) - -0.86 -0.04 -3.86 -0.30 -0.05 -0.12 -18.00
Chi-square P value (df = 1) - 0.35 0.84 0.05 0.58 0.82 0.73 < 0.01
Logistic regression models with sequential inclusion of each bundle item, and odd ratios (OR) and 95% confidence interval (CI) for in-hospital mortality. The models are adjusted for age, gender, Acute Physiology
and Chronic Health Evaluation II score, and mechanical ventilation. CVP, central venous pressure; df, degrees of freedom; MAP, mean arterial pressure; ScvO2, central venous oxygen saturation.
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0Alternative to searching for the ideal technology, lactate
monitoring for resolution of tissue hypoperfusion in
septic shock seems practical and makes physiologic
sense. A decreased in lactate (or lactate clearance) of
≥10% has been shown to be associated with improved
60-day survival [12,13]. Recently, lactate clearance >10%
instead of ScvO2 >70% as an endpoint in the EGDT
protocol was shown to result in similar amount of
fluids, vasopressors, inotropes, blood transfusions, and
in-hospital mortality [26]. Furthermore, a more aggres-
sive approach at lactate clearance of 20% or higher
every 2 hours, in addition to optimizing CVP, MAP, and
ScvO2 during the first 8 hours, in mixed ICU patients
resulted in decreased mortality [27]. One of our study
investigators (HBN) previously included lactate clear-
ance with EGDT in a 6-hour ED severe sepsis bundle
and showed that lactate clearance was associated with
d e c r e a s e dm o r t a l i t y[ 1 6 ] .I nt h ep r e s e n ts t u d yw ea l s o
found that the addition of lactate clearance to the SSC
bundle was associated with greater improvement in
outcome.
The suggestion that lactate clearance can be a replace-
ment for the more dynamic endpoint of ScvO2 should
be viewed with caution. ScvO2 as a surrogate to mixed
venous oxygen saturation reflects the balance between
oxygen delivery and oxygen consumption. Lactate eleva-
tion has been shown to be a surrogate for oxygen debt,
or oxygen deficit accumulated over time [28,29]. Lactate
clearance indicates the success of resuscitation in
improving tissue perfusion and repayment of the oxygen
debt. But the decrease in lactate also depends on the
rate of production and metabolism in the muscle, kid-
ney, and liver. Furthermore, normal lactate with persis-
tent microcirculatory blood flow alterations can still
suggest an unpaid oxygen debt [30].
The tenet of EGDT is to optimize oxygen delivery,
resolving the oxygen transport imbalance, in the hope of
improving tissue perfusion. Patients in the original
EGDT study had significant hypovolemia, oxygen deficit,
and hypoperfusion, with baseline ScvO2 <50% and lac-
tate >7 mmol/l, indicating an oxygen-delivery-dependent
state [15]. A low ScvO2 and high lactate have been
shown to be independently associated with morbidity
and mortality [31]. Achieving the ScvO2 >70% target at
6 hours was the only bundle element associated with
reduction of in-hospital mortality [18]. The recent stu-
dies advocating lactate clearance as a therapeutic end-
point enrolled patients already having a normal ScvO2
at baseline [26,27]. In those patients, therefore, fluid
resuscitation alone may be adequate to resolve tissue
hypoperfusion, achieving lactate clearance, whereas
patients with low initial ScvO2 will require blood trans-
fusion and inotrope therapy to increase oxygen delivery
[32].
In our study, we enrolled patients using the same
inclusion criteria as the original EGDT study, but the
targeted hemodynamic endpoints of CVP and ScvO2
were already optimal prior to therapy. We found that
the fluid bolus, achieving MAP >65 mmHg, and lactate
clearance were independent predictors of outcome. In
our relative hemodynamically stable patients and in
those patients in previous studies having optimal CVP
and ScvO2, therefore, targeting MAP and lactate clear-
ance may be adequate [22,33]. Our results would sug-
gest that in these patients the requirement for
specialized technology to monitor ScvO2 during the
early treatment of septic shock might be avoided.
Our study had several limitations as it was a quality
improvement effort aimed at improving the care delivery
for severe sepsis patients, rather than a randomized
examination of the effectiveness of the bundle and lac-
tate clearance. The sample size was small for a multi-
national study; however, we succeeded in showing that
the resuscitation bundle can be implemented with a
moderate level of compliance in developed and develop-
ing countries in Asia. We did not study the 24-hour
management bundle including recombinant human acti-
vated protein C, since recombinant human activated
protein C was not available in the study sites. Lactate
clearance as a bundle item in our study was more of an
observation of a resuscitation endpoint rather than part
of a guided treatment protocol. We considered patients
with initial lactate <2 mmol/l as achieving the lactate
clearance criteria. Our results were similar when we
excluded these patients from the analysis, however, and
none of the patients with the initial normal lactate had
increased values after successful initiation of the bundle
(data not shown). Finally, our approach of adding lactate
clearance to the bundle supports previous usage of
monitoring lactate in addition to hemodynamic para-
meters of CVP, MAP, and ScvO2 [16,27].
Conclusions
Our study demonstrated that adding lactate clearance as
a component of the SSC resuscitation bundle resulted in
am o r es i g n i f i c a n tm o r t a l i t yi m p r o v e m e n t ,w i t ha n
almost twofold increase in the relative risk of death
reduction. Our data are consistent with previous studies
and suggest that lactate clearance is a viable quality
improvement goal for hospitals implementing the SSC
guidelines to optimize outcome in patients with severe
sepsis and septic shock.
Key messages
￿ Implementation of the SSC resuscitation bundle at
multiple hospitals in Asia significantly increased
compliance over 18 months and was associated with
improved outcome.
Nguyen et al. Critical Care 2011, 15:R229
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Page 8 of 10￿ Lactate clearance or the decrease in lactate after
initiation of the SSC resuscitation bundle is asso-
ciated with further improvement in outcome.
￿ In severe sepsis patients with hemodynamic stabi-
lity, reflected by optimized baseline CVP and ScvO2,
the bundle items of fluid bolus administration,
achieving MAP >65 mmHg, and lactate clearance
were independent predictors of outcome.
￿ Our study results do not imply that fluid resuscita-
tion alone and the goals of MAP >65 mmHg and
lactate clearance are adequate in those patients with
evidence of significant organ hypoperfusion; that is,
low ScvO2 and high lactate levels.
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